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INTRODUCTION 
 
 Bronchial asthma is one of the diseases that are known to mankind for 
centuries. Asthma could well be considered an epidemic given the number of 
people involved. According to WHO, more than 150 million people were 
affected with asthma worldwide resulting in 1,80,000 deaths annually.1 This 
figure has increased over the last decade. Although asthma is a global disease, 
there are important differences in epidemiology, clinical spectrum and 
management practices. 
In India the prevalence of ‘asthma’ was reported as 2.4% in a 
population study on 73,605 individuals conducted simultaneously at four 
major centres in India with the use of a single definition and uniform 
methodology employing a validated questionnaire.2
The word “Asthma” originates from the Greek word asqma, which 
stands for “short breaths” or “gasp for breath”.Some believe that asthma is a 
Greek word that is derived from the verb “aazein” , meaning to exhale with 
open mouth.  
 The cause of the temporal trends in asthma prevalence is unclear, in 
part they represent change in diagnostic labeling, but there does not appear to 
have been a real increase in prevalence. A number of explanations have been 
proposed, including increased environmental pollution from motor vehicles, 
urbanization and overcrowding of population, dietary changes associated with 
affluence and the increased use of bottle feeding with cow’s milk in infancy. 
Increased mortality rates from asthma may also be partly due to changes in 
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diagnostic labeling, but the widespread use of  β-adrenergic agonists has also 
been implicated. 
 Much new information on the pathophysiology of asthma has been 
obtained in the past 15 years, and the recent advent of fibreoptic 
bronchoscopy as a research tool has allowed detailed examination of the 
respiratory tract in mild asthma. 
 It is rightly said that ‘all that wheezes is not asthma’, but equally 
all that is asthma need not wheeze. 
Despite the scientific approach of the disease, a significant proportion 
of patients do not have adequate control of the symptoms. This problem puts 
the physician in a position to probe into the so called the ‘asthma 
masqueraders’- diseases that resemble bronchial asthma and other diseases 
that commonly complicate and aggravate the disease. 
 Many of the intrathoracic and extrathoracic conditions masquerade and 
complicate or aggravate bronchial asthma. One among those conditions and is 
of much curiosity is the gastro intestinal problem that commonly 
aggravate asthma - gastrooesophageal reflux disease. 
 Though the association of respiratory diseases with the gastro intestinal 
problems have been known for more than a century, much of attention has 
been paid for the past three decades only. Prior to 1960’s much focus was 
given on the development of aspiration pneumonia etc by aspiration of gastric 
secretions as evidenced by the famous ‘mendelson’s syndrome’. The 
association of Bronchial asthma with gastro-oesophageal reflux was given 
much consideration by the western authors. 
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 Various studies have been conducted to find out the association of the 
gastro-oesophageal reflux disease with asthma, the mechanisms, and the 
clinical presentations, diagnostic approach and the therapeutic modalities for 
prevention and treatment. Much concentration was given in establishing the 
mechanism of this association. 
 However, Indian literature regarding the association of the oesophageal 
dysfunction with asthma are limited. 
 The latest concept is that “acid in the lower oesophagus due to reflux 
can provoke bronchospasm reflexly via vagus nerve,and this response is 
more pronounced in patients with bronchial asthma and reflux”. This reflux 
theory is well proved beyond doubt as the most accepted one for this 
association and so any patient who does not respond to routine asthma 
medications, or having symptoms of gastro-oesophageal reflux should be 
evaluated for the same. 
Among the common investigative modalities available to evaluate the 
gastro-oesophageal reflux, upper gastro intestinal endoscopy now plays a 
major role because besides direct visualization it allows tissue sampling. The 
endosocopic documentation of reflux oesophagitis is more relevant because it 
indicates sequelae of long standing and moderate to serve reflux disease in 
most of the occasions. 
As there are only limited studies conducted to establish this association 
we undertook this study to screen the asthmatic patients with upper 
gastrointestinal endoscopy and histology to document the reflux associated 
changes and other findings in these patients 
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REVIEW OF LITERATURE 
BRONCHIAL ASTHMA 
 
DEFINITIONS 
Asthma can be defined as an inflammatory disorder charcacterized by 
variable airflow obstruction; airway hyperresponsiveness to specific and non 
specific stimuli; and symptoms of wheezing, chest tightness, cough & 
occasionally dyspnea.3 ‘Status asthmaticus’ or ‘acute severe asthma’ is 
defined as a severe episode of asthma unrelieved by usually effective 
bronchodilator drugs. Refractory asthma is defined as asthma which is 
difficult to control despite maximal inhaled therapy and some of these 
patients will require maintenance treatment with oral steroids.4
 CAUSE OF ASTHMA 
 Asthma can arise at any age, but there are peaks of onset in childhood 
and in middle life. Childhood asthma is usually associated with atopic allergy, 
whereas adult onset asthma often (but not always) arises in non-atopic 
individuals. Both allergic and non-allergic asthma appear to have significant 
inherited components. Several lines of evidence suggest that the ability to 
make large amounts of 1gE which is directed against environmental allergens 
(atopy) is genetically conferred.5,6
 It is important to recognize that development of atopy is not sufficient 
to cause allergic asthma. Nervertheless, atopic allergy is an important inducer 
of episodic symptoms in those who are already sensitized to airbone allergens. 
Asthmas arising de novo in adulthood is less frequently associated with atopy. 
Many individuals with later onset asthma appear to develop the condition for 
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the first time following upper respiratory tract infections. Moreover most 
individuals with asthma experience acute exacerbations when they develop 
upper respiratory tract infections. 
Occupational asthma is an important cause of ill health in the work 
place. A wide range of organic and inorganic materials have been implicated 
as causes of occupational asthma. 
BRONCHIAL HYPER-RESPONSIVENESS7,8,9
 Asthma is characterized by marked variation in the caliber of the intra-
pulmonary airways over short periods of time. In addition asthmatic 
individuals often report acute episodes of asthma on exposure to non-specific 
irritants such as cold air, inorganic dusts, cigarette smoke, perfumes, paints , 
pesticides spray etc,. These are not allergic responses, but are exaggerated 
responses of the airways to the non specific irritants. This phenomenon is 
termed non-specific bronchial hyper-responsiveness. Some agents act 
directly on the airway smooth muscles (histamine, methacholine, etc) while 
others act indirectly either by inducing the release of mast cell mediators 
(adenosine etc) or through neural reflex mechanisms. 
Inflammatory events in the Bronchial mucosa 
 In patients with allergic asthma, exposure to a relevant allergen causes 
degranulation of mast cells present in the airway lumen and airway mucosa. 
This leads to the release of histamine and a range of newly formed mediators, 
which induce bronchoconstriction, oedema, mucus secretion and 
vasodilatation. Eosinophils are a characteristic feature of asthmatic 
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inflammation and are capable of causing considerable damage to the 
bronchial epithelium. 
 Eosinophils contain several basis proteins (major basic protein, 
eosinophil cationic protein, eosinophil derived neurotoxin, and eosinophil 
peroxidase) which induce mast cell degranulation directly. Exposure of 
autonomic nerve endings beneath and within the epithelium appears to 
enhance the inflammatory response through the release of the neuropeptides 
substance P, neurokinin A, and calcitonin-gene-related peptide. 
Physiology of asthma: 
 In the presence of airway inflammation and bronchial irritability, a 
wide range of insults lead to transient smooth muscle contraction. More 
prolonged bronchoconstriction and airflow obstruction arise when a chronic 
inflammatory process is set in train with mucosal oedema, mucus secretion 
and epithelial damage. These changes in airways caliber affect both large and 
small airways and lead to an overall increase in airflow resistance. Most of the 
airways resistance in health and disease is due to small airways. Thus it is 
principally the obstruction of small bronchioles which leads to increased 
airflow resistance in asthma.The FEV1 and PEFR are decreased and disturbed 
airflow patterns are clinically audible as wheeze. 
Clinical recognition of asthma10,11
 The cardinal symptom of asthma is generally thought to be wheezing. 
However a few asthmatics say that they never wheeze, and ,many describe 
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other airways symptoms such as cough with or without sputum production, 
chest tightness or simply shortness of breath. 
 Asthmatic wheezing is polyphonic, and is produced by vibrations set 
up in small airways that are almost closed off. Just as wheeze signifies 
narrowing of the airways, so does the sensation of tightness. In asthma, the 
sensation partly reflects the efforts required to breath and partly arises from 
the central airways., with those deeper in the lungs being devoid of sensation.  
 Exertional shortness of breath for the asthmatic has both a variable 
component, which tallies with the waxing and waning of the airways 
narrowing and a persistent more fixed component. 
 Cough is insufficiently emphasized as a symptom of asthma. However, 
it is one of the commonest symptoms of asthma in children and can be a lone 
symptom of the condition in adults. 
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GINA CLASSIFICATION OF ASTHMA SEVERITY BEFORE 
TREATMENT 12
Step Indications 
Step 1 
Intermittent 
Symptoms < once/week 
Brief Exacerbations 
Nocturnal symptoms ≤ 2 x/month 
FEV1/PEF ≥ 80% 
PEF/FEV1 variability < 20% 
Step 2 
Mild persistent 
Symptoms > once/week; < once/day 
Exacerbations may affect activity/sleep 
Nocturnal symptoms > 2x/month 
FEV1/PEF ≥ 80% 
PEF/FEV1 variability 20%-30% 
Step 3 
Moderate persistent 
Symptoms > once/week; < once/day 
Exacerbations may affect activity/sleep 
Nocturnal symptoms > 1x/week 
FEV1/PEF 60%-80% 
PEF/FEV1 variability > 30% 
Step 4 
Severe Persistent 
Symptoms daily 
Frequent exacerbations 
Frequent nocturnal symptoms 
Limitation of physical activities 
FEV1/PEF ≥ 60% 
PEF/FEV1 variability > 30% 
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NAEPP Classification of Asthma Severity Before Treatment in Adults 
and Youths 12 Years and Older 13
Persistent Component of 
Severity 
Intermittent 
Mild Moderate Severe 
Symptoms ≤2 days/week 
> 2 days per 
week but 
not daily 
Daily Throughout the day 
Night time 
awakenings ≤2 x/month 3-4x/month 
< 1x/week 
but not 
nightly 
Often 7x 
/week 
Short acting 
beta-against 
use for 
symptoms 
≤2 days/week 
> 2 days per 
week but 
not >1x/day
Daily 
Several 
times per 
day 
interference 
with normal 
activity 
None Minor limitation 
Some 
limitation 
Extremely 
limited 
Pulmonary 
function 
Normal FEV, 
between 
exacerbations; 
FEV1≥80% 
predicted, 
FEV1/FVC 
normal 
FEV1<80% 
predicted; 
FEV1/FVC 
normal 
FEV1<60% 
but <80% 
predicted; 
FEV1/FVC 
reduced ≥5% 
FEV1<60%
; 
FEV1/FVC 
reduced 
>5% 
Exacerbations 
(consider 
frequency and 
severity) 
0-1 per year  > 2 per year  
 
 
ROLE OF PULMONARY FUNCTION TESTS 
Pulmonary function tests (PFTs) are essential for diagnosing asthma. 
In patients with asthma, PFTs demonstrate an obstructive pattern, the 
hallmark of which is a decrease in expiratory flow rates. Patients experience a 
reduction in the forced expiratory volume over 1 sec (FEV1) and a 
proportionally smaller reduction in the forced vital capacity (FVC). These 
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reductions produce a decreased FEV1/FVC ratio (generally <0.70). With mild 
obstructive disease that involves only the small airways, the FEV1/FVC ratio 
may be normal, and the only abnormality may be a decrease in airflow at 
midlung volumes (forced expiratory flow, 75%). Patients with lung 
hyperinflation have an increased residual volume and increased residual 
volume-total lung capacity ratio. The flow-volume loop demonstrates a 
decreased flow rate for any lung volume and is useful to rule out other causes 
of dyspnea, such as upper airway obstruction or restrictive lung disease. 
The clinical diagnosis of asthma is supported by an obstructive pattern 
that improves after bronchodilator therapy. Improvement is defined as an 
increase in FEV of >12%1  and 200 cc after 2-3puffs of a short-acting 
bronchodilator. In patients with chronic, severe asthma with airway 
remodeling, the airflow obstruction may no longer be completely reversible. 
In these patients, an alternative method of establishing the maximal degree of 
airway reversibility is to repeat the spirometry after a course of oral 
corticosteroids (usually 40 mg/day PO in adults for 10 days). 
Lack of demonstrable airway obstruction or reactivity still does not 
rule out a diagnosis of asthma. In cases in which the spirometry is normal, the 
diagnosis can be substantiated by showing heightened airway responsiveness 
to a methacholine or histamine challenge. A chest radiograph should be 
obtained to eliminate other causes of dyspnea, cough, or wheezing in patients 
being evaluated for asthma. 
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NOCTURAL ASTHMA 14,15
 Noctural asthma is an integral part of asthmatic symptomatology. 
Indeed, it is so characteristic of untreated condition that asthma should not be 
diagnosed if it is absent. Symptomatically the subject awakes around 3 to 5 
am with cough, wheezing or chest tightness. Even if sleep itself is not 
disturbed, lung function at this time will still be abnormal – the morning dip. 
Likewise, asthmatic symptoms are more likely to be troublesome on 
awakening. Improvement follows during the day, so that better lung function 
and freedom from symptoms are most likely to prevail at 4 pm. 
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GASTRO OESOPHAGEAL REFLUX DISEASE 
GERD is one of the most prevalent gastrointestinal disorders. 
Population based studies show that GERD affects 20% of adults, who report 
atleast weekly episodes of heart burn, and upto 10% complain of daily 
symptoms. Reflux is considered ‘pathological’ when it causes symptoms or 
complications. ‘Reflux’ or ‘peptic’ oesophagitis indicates oesophageal 
mucosal damage due to the irritant effect of the refluxed gastric contents on 
the oesophageal squamous mucosa. Oesophagitis is not a prerequisite for the 
diagnosis of reflux disease; indeed, it is absent in the majority of patients with 
reflux disease. 
 
PATHOGENESIS: 
 The pathogenesis of GERD is complex, resulting from an imbalance 
between defensive factors protecting the esophagus (antireflux barriers, 
esophageal acid clearance, tissue resistance) and aggressive factors from the 
stomach (gastric acidity, volume, and duodenal contents). 
 
ANTIREFLUX BARRIERS 
It includes the intrinsic LES, diaphragmatic crura, the intra-abdominal 
location of the LES, the phrenoesophageal ligaments, and the acute angle of 
His 
The LES involves the distal 3 to 4 cm of the esophagus and at rest is 
tonically contracted. It is the major component of the antireflux barrier, 
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being capable of preventing reflux even when completely displaced from the 
diaphragmatic crura by a hiatal hernia. 
 
Modulators of Lower Esophageal Sphincter Pressure 16
  Increase LES Pressure Decrease LES Pressure 
Gastrin Secretin 
Motilin Cholecystokinin 
Substance P Somatostatin  
Hormones/Peptides 
  VIP 
α-Adrenergic agonists α-Adrenergic antagonists 
β-Adrenergic antagonists β-Adrenergic agonists 
Neural agents 
Cholinergic agonists Cholinergic antagonists 
Protein Fat 
  Chocolate 
Foods 
  Peppermint 
Histamine Theophylline 
Antacids Prostaglandins E2 and I2 
Metoclopramide Serotonin 
Domperidone Meperidine 
Cisapride Morphine 
Prostaglandin F2α Dopamine 
  Calcium channel blockers
  Diazepam 
Miscellaneous 
factors 
  Barbiturates 
 
The oblique entrance of the esophagus into the stomach creates a sharp 
angle on the greater curve aspect of the gastroesophageal junction, the angle 
of His.  
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MECHANISMS OF REFLUX 
Transient Lower Esophageal Sphincter Relaxations 17
Transient LESRs are the most frequent mechanism for reflux in 
patients with healthy sphincter pressures. Transient LESRs occur 
independently of swallowing, are not accompanied by esophageal peristalsis, 
persist longer (>10 seconds) than swallow-induced LESRs, and are 
accompanied by inhibition of the crural diaphragm.Transient LESRs account 
for nearly all reflux episodes in healthy subjects and 50% to 80% in GERD 
patients depending on the severity of associated esophagitis . 
  
ESOPHAGEAL ACID CLEARANCE 18
The second tier against reflux damage is “esophageal acid clearance.” 
This phenomenon involves two related but separate processes: “volume 
clearance,” which is the actual removal of the reflux material from the 
esophagus, and “acid clearance,” which is the restoration of normal 
esophageal pH following acid exposure through titration with base from 
saliva and esophageal gland secretions.  
 
SALIVARY AND ESOPHAGEAL GLAND SECRETIONS 19,20,21
Saliva is the second essential factor required for normal esophageal 
acid clearance. Compared with gastric acid, saliva is a weak base with a pH of 
6.4 to 7.8. Although saliva is ineffective in neutralizing large acid volumes (5 
to 10 mL), it easily neutralizes the small amount of acid remaining in the 
esophagus after several peristaltic contractions.  
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Modulation of salivation may contribute to GERD. Decreased 
salivation during sleep is the reason that nocturnal reflux episodes are 
associated with markedly prolonged acid clearance times.22 Xerostomia is 
associated with prolonged esophageal acid exposure and esophagitis. 
Cigarette smoking promotes GER. Originally attributed to nicotine's effect on 
lowering LES pressure, cigarette smokers also have prolonged esophageal 
acid clearance times due to hyposalivation.23 Finally, the esophagosalivary 
reflex is impaired in patients with reflux esophagitis and individuals with 
strictures.This is a vasovagal reflex demonstrated by perfusing acid into the 
esophagus, which stimulates salivation. This reflex explains the symptoms of 
waterbrash (copious salivation) observed in some reflux patients.24
In addition to saliva, the aqueous bicarbonate-rich secretions of the 
esophageal submucosal glands dilute and neutralize residual esophageal acid. 
Acid refluxing into the esophageal lumen stimulates these glands and helps 
neutralize the acid, even if swallowing does not occur.25,26
 
TISSUE RESISTANCE 27
Tissue resistance can be subdivided into pre-epithelial, epithelial, and 
postepithelial factors, which act together to minimize mucosal damage from 
the noxious gastric refluxate. The functional components of tissue resistance 
include the ability of the esophageal epithelium to buffer and extrude 
hydrogen ions. Intracellular buffering is accomplished by negatively charged 
phosphates and proteins, as well as bicarbonate ions. 
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GASTRIC FACTORS 
Gastric factors (volume and ingredients in the gastric refluxate) are 
potentially important in the production of reflux esophagitis.  
 
GASTRIC ACID SECRETION 28,29
Acid and activated pepsin are the key ingredients of the gastric 
refluxate producing esophagitis. Overall, gastric acid secretion is normal in 
patients with GERD. Local distribution of acid rather than total gastric 
secretion may be more relevant to the pathogenesis of GERD.  
H. pylori infection, especially with the cagA+ virulent strain, is a 
“biological antisecretory agent” that lowers gastric acidity, thereby possibly 
protecting from the development of severe esophagitis and Barrett's 
esophagus.  
 
DUODENOGASTRIC REFLUX 30
Along with acid and pepsin, duodenal contents may be injurious to the 
esophageal mucosa. Animal studies demonstrate that conjugated bile acids 
produce their greatest injury in the presence of acid and pepsin, whereas 
trypsin and the deconjugated bile acids are damaging in a more neutral 
environment. These experiments suggest that duodenogastric reflux into the 
esophagus predisposes to complications of GERD, however, the accurate 
measurement of duodenogastric reflux is difficult. Traditionally, this 
phenomenon was defined indirectly by measuring the esophageal pH greater 
than 7 (i.e., “alkaline reflux”). 
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 DELAYED GASTRIC EMPTYING 31
Recent investigations found only a 6% to 38% incidence of delayed 
gastric emptying, regardless of the severity of the esophagitis. Delayed gastric 
emptying is a major factor contributing GERD in some groups such as 
diabetic patients with autonomic peripheral neuropathy 
 
SYMPTOMS 
HEART BURN 
 The classic symptom of GERD, with patients generally reporting a 
burning feeling, rising from the stomach or lower chest and radiating toward 
the neck, throat, and occasionally the back.It occurs postprandially, 
particularly after large meals or after ingesting spicy foods, citrus products, 
fats, chocolates, and alcohol. The supine position and bending over may 
exacerbate heartburn. 
 
 ACID REGURGITATION AND DYSPHAGIA 
 The effortless regurgitation of acidic fluid, especially after meals and 
worsened by stooping or the supine position, is highly suggestive of 
GERD.Dysphagia is reported by more than 30% of individuals with GERD. It 
usually occurs in the setting of long-standing heartburn with slowly 
progressive dysphagia for solids.  
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OTHER SYMPTOMS 
Water brash, odynophagia, burping, hiccups, nausea, and vomiting. 
Water brash is the sudden appearance in the mouth of a slightly sour or salty 
fluid. It is not regurgitated fluid, but rather secretions from the salivary glands 
in response to acid reflux.  
 
EXTRAESOPHAGEAL MANIFESTATIONS  
GER may be the cause of a wide spectrum of conditions including 
noncardiac chest pain, asthma, posterior laryngitis, chronic cough, recurrent 
pneumonitis, and even dental erosion. Some of these patients have classic 
reflux symptoms, but many are “silent refluxers,” contributing to problems in 
making the diagnosis. 
 
CHEST PAIN  
GER-related chest pain may mimic angina pectoris, having a queezing 
or burning quality; being in a substernal location; and radiating to the back, 
neck, jaws, or arm. It frequently is worse after meals, can awaken the patient 
from sleep, and may worsen during emotional stress. Heavy exercise, even 
treadmill testing, may provoke GER.Reflux-related chest pain may last for 
minutes to hours, often resolves spontaneously, and may be eased with 
antacids. The majority of patients with GERD-induced chest pain have 
heartburn symptoms. 
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ASTHMA AND OTHER PULMONARY DISEASES 32,33,34
The prevalence of GERD in asthmatics is estimated between 34% and 
89%, depending on the group of patients studied and how GERD is defined 
(e.g., symptoms or 24-hour pH monitoring). Symptomatic GERD is an 
important comorbid condition in asthma patients, being associated with 
greater asthma severity. GERD should be considered in asthmatics who 
present in adulthood, those without an extrinsic (allergic) component, 
and those not responding to bronchodilators or glucocorticoids. [Up to 
30% of patients with GERD-related asthma have no esophageal complaints. 
Other pulmonary diseases associated with GERD include aspir-ation 
pneumonia, interstitial pulmonary fibrosis, chronic bronchitis, bronchiectasis, 
and possibly cystic fibrosis, neonatal bronchopulmonary dysplasia, and 
sudden infant death syndrome. 
 
EAR, NOSE, AND THROAT DISEASES 35
GERD may be associated with a variety of laryngeal symptoms and 
signs, of which “reflux laryngitis” is the most common. These patients present 
with hoarseness, globus sensation, frequent throat clearing, recurrent sore 
throat, and prolonged voice warm-up. Ear, nose, and throat signs attributed to 
GERD include posterior laryngitis with edema and redness,vocal cord ulcers 
and granulomas, leukoplakia, and even carcinoma. These changes are usually 
limited to the posterior third of the vocal cords and interarytenoid areas, both 
in close proximity to the upper esophageal sphincter.  
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GERD is the third leading cause of chronic cough (after sinus problems 
and asthma), accounting for 20% of cases.Dental erosion, the loss of tooth 
structure by nonbacterial chemical processes, can be caused by GER in 
healthy subjects and patients with bulimia. Microaspiration of gastric contents 
is the most likely etiology of these complaints. 
Diagnostic Tests for Gastroesophageal Reflux Disease 
Tests for Reflux 
Intraesophageal pH monitoring  
Ambulatory bilirubin monitoring (bile reflux)  
Ambulatory impedance and pH monitoring (nonacid reflux)  
Barium esophagogram  
Tests to Assess Symptoms 
Empirical trial of acid suppression  
Intraesophageal pH monitoring with symptom analysis  
Tests to Assess Esophageal Damage  
Endoscopy  
Esophageal biopsy  
Barium esophagram  
Tests to Assess Esophageal Function 
Esophageal manometry  
Esophageal impedance  
 
ENDOSCOPY  
Upper endoscopy is the standard for documenting the presence and 
extent of esophagitis and excluding other etiologies for the patient's 
symptoms. However, only 20% to 60% of patients with abnormal 
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esophageal reflux by pH testing have esophagitis at endoscopy. Thus, the 
sensitivity of endoscopy for GERD is poor, but it has excellent specificity 
at 90% to 95%.36
The earliest endoscopic signs of acid reflux include edema and 
erythema, but these findings are nonspecific and vary dependent on the 
quality of endoscopic visual images.More reliable signs are friability, 
granularity, and red streaks. Friability (easy bleeding) results from the 
development of enlarged capillaries near the mucosal surface in response to 
acid. Red streaks extend upward from the esophageal junction along the 
ridges of the esophageal folds. Erosions develop with progressive acid injury, 
characterized by a shallow break in the mucosa with a white or yellow 
exudate surrounded by erythema. Typically, erosions begin at the esophageal 
junction, occurring along the tops of mucosal folds where acid injury is most 
prone, and they may be single or multiple. Erosions can also be caused by 
nonsteroidal anti-inflammatory drugs, heavy smoking, and infectious 
esophagitis. Ulcers reflect more severe esophageal damage, being deeper into 
the mucosa or submucosa and either isolated along a fold or surrounding the 
esophageal junction. Multiple classification systems for esophagitis have been 
proposed. .In Europe the most popular scheme is the Savary-Miller 
classification. The most thoroughly evaluated esophagitis classification is the 
Los Angeles system, and gaining acceptance in the United States and 
Europe.37,38,39
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ENDOSCOPIC GRADING SYSTEMS FOR ESOPHAGITIS  
Savary-Miller Classification 
Grade 0 Not applicable 
Grade I Single, erosive, or exudative lesion on 1 longitudinal fold 
Grade II Multiple erosions on more than 1 longitudinal fold 
Grade III Circumferential erosions 
Grade IV Ulcer, stricture, or short esophagus, isolated or associated with 
grades I-III 
Grade V Barrett's esophagus ± grades I-III 
Los Angeles Classification 
Grade A 1 or more mucosal breaks confined to folds, ≤5 mm 
Grade B 1 or more mucosal breaks >5mm confined to folds but not 
continuous between tops of mucosal folds 
Grade C Mucosal breaks continuous between tops of 2 or more mucosal 
folds but not circumferential 
Grade D Circumferential mucosal break 
 
 
HETZEL ‘S CLASSIFICATION 
GRADE    APPEARANCE  
0   Normal oesophageal mucosa 
 
1  Mucosal oedema , hyperemia and/or friability of the mucosa 
 
2  Superficial erosions involving <10%of the mucosal surface in 
the last 5cm of the oesophageal squamous mucosa 
 
3   Superficial erosions / ulcerations involving 10 – 50% of the 
distal oesophagus 
 
4   Deep peptic ulceration any where in the oesophagus or 
confluent erosions of >50% of the distal oesophageal squamous 
mucosa  
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24- h pH-metry 
This is a test to evaluate esophageal acid exposure (measured in terms 
of pH, mathematical way of measuring amount of acidity or hydrogen ion 
concentration) and is considered "gold standard" for diagnosing GERD. This 
test is not only used to diagnose GERD but also used to determine the 
effectiveness of medications used in its treatment in suppressing acid 
secretion from stomach. 
 
BIOPSY FINDINGS40
• Edema and basal hyperplasia (non-specific inflammatory changes)  
• Lymphocytic inflammation (non-specific)  
• Neutrophilic inflammation (usually due to reflux or Helicobacter 
gastritis)  
• Eosinophilic inflammation (usually due to reflux)  
• Goblet cell intestinal metaplasia or Barretts esophagus  
• Elongation of the papillae  
• Thinning of the squamous cell layer  
• Dysplasia or pre-cancer  
• Carcinoma  
 
NEGATIVE ENDOSCOPIC REFLUX DISEASE (NERD)41
• Patients with classic symptoms of GERD and normal esophageal 
mucosa have been classified as having endoscopy-negative reflux 
disease (ENRD), symptomatic GERD, or NERD. Nonerosive reflux 
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disease (NERD) is the most common phenotypic presentation of 
gastroesophageal reflux disease (GERD). 
 
PATHOPHYSIOLOGY 
Physiologic studies in NERD patients demonstrated minimal 
abnormalities when compared to normal subjects. Nonerosive reflux disease 
patients have a slightly higher rate of failed peristaltic contractions, defined as 
nontransmitted contractions or contraction waves that do not traverse the 
entire esophagus. Additionally, NERD patients demonstrate mildly reduced 
mean lower esophageal sphincter (LES) resting pressure and distal amplitude 
contractions as compared with normal subjects. Hiatal hernia is a relatively 
uncommon anatomic finding in NERD patients as compared with patients 
with erosive esophagitis or Barrett's esophagus. Cameron et al reported that 
the hiatal hernia prevalence among NERD patients is only 29% as compared 
to 71% of the erosive esophagitis and up to 96% of the long-segment Barrett's 
esophagus patients. The rarity of hiatal hernia suggests that transient lower 
esophageal sphincter relaxation (TLESR) is the predominant underlying 
mechanism for GER in patients with NERD. 
 
GASTRO-OESOPHAGEAL REFLUX DISEASE AND BRONCHIAL 
ASTHMA 
 The association between gastro-oesophageal reflux and respiratory 
disease has been appreciated since 1848 when simpson described a patient 
who died of aspiration pneumonia after an anaesthetic.42,43
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 In 1934 Bray suggested that, in asthmatics, gastric distension due to 
dietary indiscretion led to reflex mediated bronchoconstriction via vagus 
nerve.44
 In 1946 Mendelson called attention to the ‘acute asthma-like reaction’ 
following aspiration of liquid gastric contents during induction for 
anaesthesia. 
 In 1962 Kenndey described a group of 25 patients with chronic 
bronchitis, bronchiectasis or pneumonia due to silent gastro oesophagcal 
reflux.46,46
 Mansfield and Stein suggested that the vagal nerve might mediate 
bronchoconstriction in asthmatic patients when stimulated by acid in the 
oesophagus. This they supplemented the findings by experiments in dogs. 
Spaulding et al showed in selected control groups using a procedure of acid 
stimulation that the greatest changes occurred in the Total Airway Resistance 
in asthmatic patients with positive acid challenge in whom there was an 
association between attacks of asthma and symptoms of gastroesophageal 
reflux.47,48
 
MECHANISMS & PATHOPHYSIOLOGY 49-52
 Two basic mechanisms are considered to be responsible for the 
pulmonary manifestations of gastro-oesophageal reflux. First is the 
pulmonary aspiration of refluxed gastric contents producing acid induced 
injury and infection. Second is the neurally mediated reflex 
bronchoconstriction secondary to irritation of oesophageal mucosa. 
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ASPIRATION OF REFLUXATE INTO RESPIRATORY SYSTEM 
 This mechanism could be further elaborated under two subcategories.53,54
1. Overt macro aspiration of liquid gastric contents associated with 
chemical pneumonias and 
2. Microaspiration of liquid gastric contents resulting in stimulation of 
upper airway receptors. 
 The macroaspiration theory is well documented by the earlier authors 
as mentioned earlier. However the macroaspiration of gastric contents is not a 
relatively common association in the patients with bronchial asthma. The 
response to entry of gastric contents into the lungs depends on the volume of 
material aspirated, the presence or absence of particulate material and the pH 
of the aspirate. Aspiration of large quantities of highly acidic material (greater 
than 1.0ml/kg, pH<2.5) has been shown to cause reflex airway closure 
associated with hemorrhagic pneumonitis, non cardiac pulmonary oedema 
and severe hypoxemia. The effect is that of a chemical burn. 
 Such overt signs of aspiration have rarely been described in association 
with gastro-ocsophageal reflux in the absence of state in which there is an 
altered level of consciousness. Because the absence of clinical and radiologic 
evidence of classic acid aspiration in a proportion of patients with reflux 
associated pulmonary disorders, alternative explanations have now been 
hypothesized to explain the pathogenesis. 
 In recent reviews, the words “micro-aspiration” or “silent aspiration” 
have begun to appear to explain how gastro-oesophageal reflux could provoke 
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bronchospasm. The implication of the terms is aspiration limited to the upper 
airway without progression into the lower respiratory tract. Such a 
phenomenon has been described by Wynne and associates using experimental 
solutions of 0.1 ml injected into the oropharynx of mice, noting the 
physiological changes were limited to the tracheal mucosa and specifically to 
the surface cell layer. 
 Microaspiration of gastric contents may be sufficient to stimulate 
airway receptors to affect respiratory function. Tracheal irritant receptors are 
believed to be situated in the upper airway epithelium. Tuchmann et al 
compared the airway responses following tracheal or oesophagcal 
acidification in the cat and found the tracheal acidification caused significant 
increase in airway resistance in contrast to the oesophageal acidification. This 
study supports the view that microaspiration into the trachea is a much more 
likely mechanism for bronchopasm associated with gastroesophageal reflux 
than simple acid reflux into the oesophagus.55
 A number of other studies by Simmonsson et al (1967) using acetic 
acid aerosol, Larsell O’ et al (1974) using acetic acid aerosol and Utell et al 
(1983)using sulphuric acid acrosol showed to stimulate bronchoconstriction.57
 Moreover studies in dogs by Sullivan-CE (1979) and Finer et al (1976) 
have suggested that airway protective mechanisms including cough may be 
diminished during sleep. 
 Jolley and co-workers reported that patients with respiratory disorders 
associated with gastro-oesophageal reflux have an increased frequency of 
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gastro-oesophageal reflux during sleep as well as symptoms of brochospasm. 
However Reich et al (1977) and Ghaed and Stein (1979) in their studies to 
prove this theory could not convincingly demonstrate the microaspiration 
mechanism by which gastric contents could stimulate bronchospasm.58
 A third theory that has gained increased popularity because of the 
inability to convincingly document microaspiration even by sensitive 
radiolabelled isotopic scintigraphic techniques is that “reflux of gastric 
contents into the oesophagus alone may stimulate mucosal receptors that are 
capable of reflexly altering pulmonary mechanics”. Indeed studies by 
Mansfield et al found that acidification of the oesphagus has been shown to 
increase the total lung resistance in dogs and humans in the presence of 
oesophagitis. 
 A variety of oesophageal receptors have been described by vagal 
unitary recordings including stretch receptors (Andrew 1956), 
thermoreceptors (EL Quazzani & Mei 1982) and acid sensitive receptors 
(Harding & Titchen: 1975); The afferent input from such receptors may be 
capable of reflexly altering control of respiratory timing or bronchial smooth 
muscle tone. EI. Quazzani and Mei found that stimulation of chemoreceptors 
in the oesophagus and stomach produced changes in the oesophageal motility 
and respiratory frequency. 
 Spaulding et al (1982) performed intra- oesophageal acid perfusion 
challenge in asthmatic subjects with and without gastro-oesophgeal reflux, 
non asthmatic subjects with reflux and normal subjects. Spirometric and total 
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lung resistance were measured before and after infusion. There were no 
changes in the pulmonary function except in the asthmatic subjects who had a 
positive acid challenge, changes where mainly in the total lung resistance 
which significantly increased with reflux and decreased when symptoms 
where relieved with antacids. The response was even greater in asthmatic 
subjects who associated reflux symptoms with attacks of asthma.56 
 Davis et al (1983) studied the respiratory response to intraoesphageal 
acid infusion in asthmatic children during sleep and concluded that during 
sleep the presence of acid in the lower oesophagus can trigger 
bronchoconstirction in asthmatic children with a positive Bernstein test and 
that these children appear to be more susceptible to the bronchoconstrictive 
effects of intra oesophageal acid at 4 to 5 am than at midnight.57-60
 Anderson, Schmidt et al (1986) conducted acid infusion study in 
subjects with oesophagitis but without pulmonary disease, bronchial asthma 
without oesphagitis and having oesophagitis and asthma. They observed that a 
modest bronchoconstriction when acid is present in the osophagus is seen in 
patients with serve asthma and oesophagitis. Atropine inhibits 
bronchonstricition indicating a vagal mediation. 
 Herve et al (1986) studied the effect of intra-oesophageal acid 
perfusion in asthmatic subjects and found that perfusion of acid into the distal 
oesophagus caused bronchoconstriction in asthmatic subjects with gastro-
oesophageal reflux and increased the bronchoconstriction produced by 
isocapnic hyperventilation and by methacholine in asthmatic subjects without 
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regard for the presence of gastro-oesophageal reflux.61,62 Study by Ekstrom et 
al (1989) concludes that this acid stimulation during daytime in majority of 
the asthmatic subjects is not a strong and immediate trigger of asthma.63
 
BRONCHOSPASM AS A TRIGGER FOR GASTRO-OESOPHAGEAL 
REFLUX. 
 Very little attention has been focused on the possibility that altered 
respiratory mechanics might cause oesophageal dysfunction. In 1961, 
Clemencon and Osterman advanced the theory that disturbed intrapleural 
pressure relationship could predispose to hiatal herria and gastro-oesohageal 
reflux. Yet no proof has been offered to support this concept.64,65
 However much attention was paid to the altered diaphragmatic 
function in this regard. Transdiaphragmatic pressure is the major force 
for the gastro-oesophageal reflux. The observation that asthmatic patients 
maintain ventilation by increased neuromuscular output during obstruction 
implies that there is an associated increase in the transdiaphragmatic pressure. 
Hughs and colleagues speculated that these pressure swings might pump 
gastric content into the oesophagus. 
 Most of the previous studies have shown that gastro ocsophageal reflux 
associated with bronchospasm seem to have increased reflux during sleep. In 
normal subjects, transdiaphragmatic pressure swings and phasic 
diaphragmatic EMG activity increases on falling asleep, particularly 
during REM sleep. Tabachink and co-workers observed in asthmatic subjects 
that during REM sleep there is actually abnormal chest wall movement with 
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paradoxical inward movement of the ribcage during inspiration. In association 
there was significant increase in the electrical activity of the diaphragm as 
well as a considerable increase in the abdominal excursions during 
inspiration. These findings suggest further augmentation of diaphragmatic 
contraction in asthmatic patients during REM sleep and thus increasing the 
gastro-oesophageal reflux by increasing the trans diaphragmatic pressure. 
 
ROLE OF DIAPHRAGM ITSELF IN THE ANTI REFLUX 
MECHANISM 
 Intra luminal manometry of the oesophagus has revealed the existence 
of a high pressure zone at the gastro-ocsophageal junction, characterized by 
an area of elevated basal pressure and a respiratory induced pressure 
oscillation that are of greater magnitude than those simultaneously found in 
the adjacent stomach and oesophagus. Recent human studies indicate that the 
degree of inspiratory depth contributes significantly to the recorded amplitude 
of the pressure oscillation. Studies in cat model showed that the respiratory 
oscillations in this pressure is primarily due to active diaphragmatic 
contraction during inspiration. 
Although diaphragm has been classically considered as being one 
single functional unit, recent studies also suggest different actions of the 
costal and crural (vertebral) parts of the muscle. They have different 
embryologic and evolutionary origins in fact the crural part develops in the 
dorsal mesentery of the oesophagus, which is believed to be responsible for 
the anti reflux mechanism.  
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 Hyperinflation associated with bronchospasm places the diaphragm at 
serious disadvantage because of geometrical flattening. 
 All these factors that cause the alteration in the performance of the 
diaphragmatic contraction have adverse effect on the anti reflux mechanisms 
of the diaphragm and, may increase the incidence of gastro-oesophageal 
reflux in asthmatics. 
 In recent years investigators have tended to concentrate on the role of 
drugs used in the treatment of bronchospasm as contributing to the high 
incidence of gastro-oesophageal reflux seen in these patients. Goyal and 
Rattan (1973) showed in the opossum that both theophylline and isoproterenol 
cause a dose dependent relaxation of lower oesophageal sphincter. Berquist 
and associates found that gastro-esophageal reflux is induced in most normal 
adults who achieve therapeutic serum levels of theophylline. These studies 
have led to the concept that high incidence of gastro-oesophageal reflux 
associated with bronchospasm is drug induced. But these effects of 
bronchodilators can not be the sole explanation in this regard in clinical 
studies in which bronchodilator therapy is discontinued before diagnostic 
evaluation of reflux, the incidence of reflux remains in the range of 25 to 
30%. In addition ,in these patients in whom the theophylline therapy is 
continued during diagnostic evaluation, there is no difference in serum 
theophylline levels between patients who do or do not have significant reflux. 
 Sontag and O’ connel suggested that most adult asthmatics regardless 
of the use of bronchodilator therapy have abnormal gastro-oesophageal reflux, 
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manifested by increased reflux frequency, delayed acid clearance during the 
day and night and diminished lower oesophageal sphincter pressure. 66 
 Moote and coworkers (1968) in their study concluded that during 
methacholine induced bronchospasm,, subjects with asthma had more 
episodes of reflux and dropped their pH to lower levels than did the control 
subjects.67
 Huberts and colleagues (1988) however failed to demonstrate any 
adverse effect of a slow release theophylline preparations on gastro-
oesophageal reflux in patients with asthma. They further suggested that 
gastro-oesophageal reflux is not a contraindication to the use of a slow release 
theophylline in subjects with asthma.68
 Ekstrom and Tibling (1989) in their study, suggested that mild 
bronchospasm is unlikely to provoke reflux in patients with asthma and 
gastro-oesphageal reflux, rather mild bronchospasm is protective against 
reflux. The reason for this observation could be that the stomach is atonic 
during stressful events such as acute attack of asthma. Another possible 
explanation could be that increased abdominal pressure during forced 
expiration with bronchopasm might squeeze the lower oesophageal sphincter 
and therefore prevent reflux as long as the lower oesophageal sphincter is 
located in the abdominal cavity.69,70
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 AIMS AND OBJECTIVES OF THE STUDY 
 
1. To document the various upper gastro-intestinal endoscopic as  well  as  
histologic findings  of  lower  oesophagus  in patients with bronchial 
asthma. 
2. To estimate the prevalence and magnitude of the reflux associated 
changes in association with bronchial asthma. 
3. To correlate frequency of association with duration of bronchial 
asthma. 
4. To correlate the frequency of association with severity of bronchial 
Asthma. 
5. To document the presence of NERD (Negative Endoscopic Reflux 
Disease) in patients with bronchial asthma. 
6. Endoscopic / histological correlation of oesophagus status in patients 
with bronchial asthma. 
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MATERIALS AND METHODS 
 
 Thirty  patients who were diagnosed to have bronchial asthma and 
having regular follow up im thoracic medicine out patient clinic were 
included in the study. From the total mass of patients through questionnaire 
those who fulfill the selection criteria were selected. The period of study is 
from February 2008 to September 2009.The materials were obtained from 
Thoracic Medicine and Medicine Departments.  
 
Selection Criteria 
1. Patients who had been diagnosed to have bronchial asthma earlier by 
history and pulmonary function tests and were on regular follow up.  
Careful history taking was done and the following group of patients 
were selected for the study.  
1. Patients who do not have satisfactory control of the symptoms in spite 
of regular treatment.  
2. Patients who experience frequent nocturnal episodes of asthmatic 
attacks  
3. Patients who have symptoms of gastro-oesphageal reflux disease.    
For  these  patients  , during  exacerbation  of  symptoms, spirometry  
is  performed  both  before  and  after  bronchodilator  administration.A  
12%  increase  (calculated  from  prebronchodilator  values  )  and  a  
200ml  increase  in  either  FEV1  or  FVC  defines  a  positive  
bronchodilator  response  and  indicates  reversibility  of  obstruction. 
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Exclusion Criteria 
 The following group of patients were excluded from the study after 
clinical examination and investigation because of the confounding factors 
which will interfere with the results.  
1. Patients with systematic Hypertension, Diabetes Mellitus, Chronic 
real failure, Rheumatological diseases.  
2. Patients who have other cardio respiratory disease like pulmonary 
Tuberculosis, Chronic Obstructive Pulmonary Diseases viz 
Emphysema, Chronic bronchitis, Bronchiectasis, Coronary atery 
disease, Congestive Cardiac Failure, Valvular Hear disease etc.  
3. Patients with habits of smoking, alcoholism, tobacco ingestion, 
NSAIDintake.  
4. Patients at extremes of age.(<13 & >60) 
5. Pregnancy 
6. A/c exacerbation of symptoms 
The patients were admitted in medical wards and detailed history taking and 
clinical examination was carried out.  
History : 
 Occupational History  
 Duration of Illness 
 Treatment History 
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Symptomatology : Frequency of attacks  
    Frequency of nocturnal episodes  
    Symptoms of attack  
    Symptoms of reflux disease  
    (Heart burn, Waterbrash, Chest pain Cough etc)  
Factors which precipitate asthmatic episodes 
H/O Systematic Hypertension, Diabetes Mellitus, Chronic Renal Failure.  
 
Family History :  H/O Atopy and allergy  
Drug History : Steroids / B2 Stimulants / Theophylline  
   Oral / parenteral/ Inhalation Routes  
   Regular / Irregular  
Physical examination: 
Cyanosis, comfortable /dyspnoeic , sensorium , Asterixis,presence of action 
of accessory muscles of respiration 
Vital Signs 
Pulse rate, regularity, Respiratory rate, Type, Temperature  
Systemic Examination 
Respiratory system - Chest Shape / symmetry / Measurements / Expansion 
/Breath sounds and adventitious sounds.  
Cardiovascular System - Signs of cardiac failure, Pulmonary Hypertension.  
Abdomen 
Central Nervous System  
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Laboratory Investigations 
 Urine Albumin , Sugar,  Blood Counts, Total WBC count, Differential 
count, RBC counts, Haemoglobin content.  
Blood Chemistry 
 Urea, Creatinine, sugar using standard calorimetric technique. Standard 
12 lead electrocardiogram with rhythm strips. X – ray chest postero anterior 
view.  
Pulmonary  Function Tests  
 In this study, GINA (Global Initiative for Asthma) Classification of 
Asthma Severity is used to classify patients. 
After establishing the disease and ruling out the exclusion factors the 
patients were prepared for endoscopy evaluation. A well informed consent 
explaining the procedure and instructions was obtained patients were 
instructed to have minimum of 6-8 hours fast during the night prior to 
endoscopy. 
 Upper gasto-intestinal endoscopy is carried out in all the patients using 
PENTEX VIDEO ENDOSCOPY SYSTEM. Prior to procedure the pharynx 
was anaesthetized using Xylocaine 4% viscous fluid as and when necessary 
.Intravenous sedation was not necessary.  
  Endoscopic rapid screening of Upper GI tract and biopsy of lower 
oesophageal region (3- 4 bits taken). Procedure time is less than 5 minutes. 
Post procedure : No complications noted.Oxygen cylinder,IV line,Emergency 
Tray were kept in endoscopy room as backup. 
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Histological assessment of the samples were done to find out the 
prevalence of histopathologic changes. Three biopsy samples were taken for 
each patient from the gastro oesophageal junction.  
Basal cell thickness, Length of papillae, and Dysplasia In Situ ( DIS ) 
were semiquantitatively scored as 0 (absent), 1 (mild),and 2 (marked) on 
hematoylin – eosin stained slides obtained from each biopsy site. Basal cell 
thickness (normal values :<15% at 2 and 4 cm and <20% at the Z – line) and 
length of papillae (Normal values <50% at 2 and 4 cm and < 66% at the Z – 
line) were recorded as a percentage of total epithelial thickness.DIS was 
scored on the basis of their size. In addition, the presence of intraepithelial 
infiltration of Eosinophils (Score 0 = absent , 1=1 eosinophil, 2 = >1 
eosinophil), Neutrophils (0 = absent ,2= present), and Necrosis / Erosions (0 = 
absent, 2= present) were noted.The presence and number of eosinophils and 
neutrophils were assessed in the whole sample and the data refer to the mean 
of the most infiltrated three high power fields.The  final  histologic  “reflux  
score”  resulted  from  the  sum  of  all  above  scores  for  each  variable  at  
all  biopsy  sites. The  sum  of  scores  of  microscopic  lesions  found  in  all  
biopsy   sites  ranged  from  0 to 22 ; a  cut – off  value  (score 2)  
distinguished  efficiently  controls   from  GERD  patients.71
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 RESULTS AND ANALYSIS 
 
SEX DISTRIBUTION 
 Out of the 30 patients entered the study 15 were males and 15 were 
females. 
 
 
No. of Patients
Male
Female
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ENDOSCOPY FINDINGS 
 Out of the 30 patients 17 had various types of abnormal findings. 
 
Normal Findings
Abnormal Findings
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AGE DISTRIBUTION 
 
Sl.No. Age No. of Patients 
1 Less than 20 4 
2 20-29 6 
3 30-39 7 
4 40-49 8 
5 Above 50 5 
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 Abnormal Endoscopy findings - Age wise Distribution 
Age Male Female Total 
Less than 20 1 0 1 
20-29 2 2 4 
30-39 3 2 5 
40-49 3 1 4 
Above 50 1 2 3 
Total 10 7 17 
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Abnormal Endoscopy findings relations with duration of illness  
 
Duration of Illness Male Female 
Less than 5 years 3 2 
5 years and above 7 5 
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INCIDENCE OF ABNORMALITIES 
Total No. of Patients – 30 
Grade I Oesophagitis 11 
Grade II Oesophagitis 1 
Grade III Oesophagitis 0 
Candidiasis 1 
Antral Gastritis 5 
Hiatus Hernia 2 
Duodenitis 2 
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REFLUX ESOPHAGITIS – SEX DISTRIBUTION 
 
 Male   -7 
 Female - 5 
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 ABNORMAL ENDOSCOPY FINDINGS VS SEVERITY OF ASTHMA 
 
Severity of Asthma Total Number Reflux Associated Lesion 
Mild & Moderate Persistent 21 13 
Severe Persistent 9 4 
Total 30 17 
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REFLUX ESOPHAGITIS VERSUS SEVERITY OF ASTHMA 
 
Severity of Asthma Total Number Reflux Associated Lesion Percentage 
Mild & Moderate 
Persistent 21 7 33.33% 
Severe Persistent 9 5 55.55% 
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REFLUX ESOPHAGITIS VERSUS DURATION OF ILLNESS 
 
Duration of Asthma Total Number Reflux Associated Lesion 
Less than 5 years 13 4  
More than 5 years 17 8 
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HISTOGICAL CHANGES IN GERD 
Score  
Findings  
0 1 2 
Basal cell thickness <15% at 2 & 4cm <20% Z-line    
Length of papillae <50% at 2& 4cm <66% Z-line   
Dysplasia in situ (DIS)    
Neutrophil invasion Absent One   Neutrophil 
>1 
Neutrophil 
Eosinophil invasion Absent One  Eosinophil 
>1 
Eosinophil 
Necrosis / Erosions  Absent  Present 
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ENDOSCOPY POSITIVITY VERSUS BASAL CELL THICKNESS 
SCORE 
 
No. of Patients with 
Positive Endoscopy 
Basal Cell Thickness 
Score No. of patients 
0 0 
1 8 12 
2 4 
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Endoscopy Negativity Versus Basal Cell Thickness Score 
 
No. of Patients with 
Negative Endoscopy 
Basal Cell Thickness 
Score No. of patients 
0 0 
1 5 18 
2 2 
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Endoscopy Positivity Versus Length of Papillae  
 
No. of Patients with 
Positive Endoscopy 
Papillary elongation 
score No. of patients 
0 0 
1 8 12 
2 4 
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Endoscopy Negativity Versus Papillary Elongation 
 
No. of Patients with 
Negative Endoscopy 
Papillary Elongation 
Score No. of patients 
0 0 
1 6 18 
2 0 
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Endoscopy Positivity Versus Eosinophil Invasion 
 
No. of Patients with 
Positive Endoscopy 
Eosinophil Invasion 
Score No. of patients 
0 0 
1 0 12 
2 12 
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Endoscopy Negativity Versus Eosinophil Invasion 
 
No. of Patients with 
Negative Endoscopy 
Eosinophil Invasion 
Score No. of patients 
0 0 
1 0 18 
2 8 
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Endoscopy Positivity Versus Neutrophil Invasion 
 
No. of Patients with 
Positive Endoscopy 
Neutrophil Invasion 
Score No. of patients 
0 0 
1 0 12 
2 12 
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Endoscopy Negativity Versus Neutrophil Invasion 
 
No. of Patients with 
Negative Endoscopy 
Neutrophil Invasion 
Score No. of patients 
0 0 
1 0 18 
2 8 
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Findings No. of Patients 
Endoscopy Positive 12 
Histopathology Positive 20 
Endoscopy negative 18 
Histopathology Negative 10 
  
 
 Histopathology Positive 
Histopathology 
Negative 
Endoscopy Positive 12 0 
Endoscopy Negative 8 10 
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COMPARATIVE ANALYSIS 
PREVALENCE OF REFLUX OESOPHAGITIS IN ASTHMATICS 
 
Study Prevalence 
S.J. Sontag et al 39% 
Kiljander et al 36% 
This Study 40% 
 
 
Oesophageal Muscosal Status 
 Sontag et al. This Study 
Normal (No oesophagitis/No 
Barrett’s) 57.5% 33.33% 
Oesophagitis without Barrett’s 29.6% 66.67% 
Barrett’s without Oesophagitis 3.2% Nil 
Barrett’s with Oesophagitis 9.7% Nil 
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 Endoscopic histopathologic Oesophagitis by asthma symptoms and 
clinical stage – Comparative Analysis 
Endoscopic 
Oesophagitis 
Histopathologic 
Oesophagitis Clinical Stage 
Tug et al This Study Tug et al 
This 
Study 
Mild & Moderate 
persistent 
(n=21) 
27% 33.3% (n=7) 55% 
61.9% 
(n=13) 
Severe Persistent 
(n=9) 18% 
55.5% 
(n=5) 36% 
77.7% 
(n=7) 
 
 
Endoscopic 
Oesophagitis 
Histopathological 
Oesophagitis 
 
Tug 
et al This study Tug et al This study 
Nocturnal attacks + 
(n=12) 24% 
58.3% 
(n=7) 47% 
75% 
(n=9) 
Nocturnal attacks  - 
(n=18) 17% 
27.7% 
(n=5) 35% 
61.1% 
(n=11) 
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DISCUSSION 
 
 Gastro-oesophageal reflux disease is one of the conditions which 
triggers or worsens the asthmatic condition and hinders with the effective 
treatment. Physiological reflux, though produces bronchocontriction by reflex 
vagal stimulation, is not strong enough to produce symptoms of asthma in 
normal individuals. Acid reflux triggers asthmatic attacks or worsens the 
symptoms of asthma in the asthmatic patients. This effect is more pronounced 
if the patients have reflux oesophagitis.  
 Many authors in earlier studies, proved that the acid application in the 
lower oesophagus can provoke bronchospasm. They used lower oesophageal 
contrinuous pH monitoring or oesophageal manometry as the diagnostic tools 
to evaluate the reflux. But in practical aspect, the reflux disease gets more 
attention because of its symptoms or complications. In that aspect, upper 
gastrointestinal endoscopy proves to be an effective diagnostic tool since it 
enables diagnosis of the reflux associated complications or disorders such as 
reflux oesphagitis, oesphageal stricture or ulcer, or Barrett’s oesophagus or 
hiatus hernia. Beside direct visualization it allows tissue sampling in doubtful 
cases.  
 But documentation of reflux oesophagitis alone is an underestimate of 
the spectrum of reflux disease, because quite a proportion of patients with 
symptomatic reflux disease do not have macroscopic evidence of reflux 
oesphagitis. So negative endoscopy does not entirely rule out the reflux 
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disease. But it is an important tool, because the therapeutic approach for the 
reflux disease based upon the endoscopic severity is the best accepted and 
effective one.  
 S.J. Sontag, T.G. Schnell and co-workers conducted endoscopic 
evaluation in a series of asthmatic patients who attended the asthma clinic. All 
asthmatics had discrete wheezing and either a previous diagnosis of asthma or 
documented reversible airways obstruction of 20%. The oesphageal mucosa 
was graded as normal if no erosion or ulcerations were present in the tubular 
oesophagus, as oesophagitis if a mucosal break with exudates (erosins and / or 
ulcerations) was present and as Barrett’s if specialized (intestinal) columnar 
epithelium was present. A hiatal hernia was diagnosed if >=2 cm of gastic 
mucosa appeared above the diaphragm during endoscopy. In their study 39% 
of the patients with asthma had oesophagitis of Barrett’s oesophagus or both. 
There was no difference in the oesophageal mucosal status between 
asthmatics who required and those who did not require bronchodilators. 58% 
of asthmatic had a hiatal hernia. They concluded that oesophagitis is common 
and independent of the use of bronchodilator therapy in asthmatics.72  
 This study was primarily aimed at finding out the prevalence of reflux 
associated changes by upper gastrointestinal endoscopy. In the patients 
attending asthma clinic majority of the patients had moderate to serve 
persistant asthmatic attacks. They were taking regular bronchodilator 
medications hence we did not randomize the patients receiving or not 
receiving bronshodilators.  
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 Since reflux oesophagitis is one of the conditions which hinders with 
effective asthma treatment, we selected the cases who do not have adequate 
control of asthma in this study. Thorough questionnaire was put to evaluate 
the gastrointestinal symptoms.  
 We also eliminated the patients who had confounding factors such as 
chronic obstructive airways disease, smoking, alcoholism, tobacco ingestion. 
NSAID intake, pregnancy, Diabetes mellitus, chronic renal failure because 
these conditions will affect the oesophageal motility and lower oesophageal 
sphineter tone so they possibly tend to produce oesophagitis and other 
endoscopic changes.  
 Sontag et al reported a prevalence of 39% of oesophagitis and / or 
Barrett’s oesophagus in their study of asthmatic patients.. In this study of 30 
patients, 7 males and 5 females had reflux oesophagiti. (23.3% and 16.67% 
respectively). Comprising a total of 40% of oesophagitis in this study.  
 Out of the 30 patients. 15were male (50%) and 15were female (50%). 
The mean age of male was 42.27 years ranging from 13 to 68 years. The 
mean age of female was 36.79 years ranging from 16 to 60 years. The mean 
duration of asthma was 7.95 years in male and 5.18 years in females.   
 
ENDOSCOPIC LESIONS  
Reflux Oesophagitis  
 Of the 30 patients studied 17 had abnormal endosopy findings thus 
comprising of 56.67%of abnormal findings in this study. Out of the 15 males 
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studied 10 had abnormal findings (66.67 %) and out of the 15 females, 7 had 
abnormal finding (46.67%). This male prepondance of lesions could not be 
explained by the disease per se alone but other factors like strenuous work ,tea 
or coffee ingestion could also play a role.  
 Of the endosocpic findings reflux associated findings were worth the 
comment. Reflux oesophagitis was found in 12 patients (40%) and pulled up 
gastro-oesophageal junction consistent with hiatus hernia was found in 2 
patients (6.67%).Of the twelve patients 11 patients had Grade 1 oesophagitis 
and one patient had grade II oesophagitis. . However, we adopted the savary 
miller scale of classification of oesophagitis but the original study by Sontag 
adopted the Hetzel classification in which small erythemas are included as 
grade I lesions. In our criteria small erythemas are not included as evidence of 
oesophagitis .Erosions, and multiple erythemata are only graded as grade 1 
oesophagitis.  
  Studies by Indian authors Agarwal et al also reported similar range of 
prevalence of reflux oesophagitis in asthmatic patients.  
 
HISTOPATHOLOGICAL  FINDINGS 
In this study, we included the histopathological correlation of reflux 
oesophagitis . Histopathological changes consistent with GERD were present 
in all the 12 patients with reflux oesophagitis.  
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 Out of the 18 patients who were endoscopically negative for reflux 
oesophagitis , 8 had findings consistent with GERD. (5 male : 3 female) 
(44.4%). 
 Tug et al conducted a study on the association between severity and 
stage of asthma symptoms in a distinctive period and gastrooesophageal 
reflux. In this study they correlated endoscopic –histopathologic oesophagitis 
by asthma symptoms and clinical stage. They reported the prevalence of 
Endoscopic oesophagitis to be 27% and histopathologic oesophagitis to be 
55% in patients with mild-intermittent / persistent asthma. In moderate 
persistent asthma, the prevalence was 18% and 36% respectively.They  also  
correlated  the  frequency  of  GER  symptoms  and  endoscopic – 
histopathologic  oesophagitis  in  patients  with  and  without  nocturnal  
symptoms. Histopathological diagnosis was based on the definition given by 
Ismail – Beigi et al.73
 In this study, the prevalence of Endoscopic oesophagitis is 33.3% 
(n=7) and histopathological oesophagitis is 61.9%(n=13) in patients with mild 
and moderate persistent asthma. 
 In patients with severe asthma, the endoscopic prevalence is 55.5% 
(n=5)and histopathologic prevalence is 77.7%(n=7). 
 The  prevalence  of  Endoscopic  oesophagitis  and Histopathologic  
oesophagitis  in  patients  with  nocturnal  attacks  were  58.3%(n=7) and  & 
75%(n=9) respectively, In  patients without  nocturnal  attacks the  prevalence  
is  27.7% (n=5)  and  61.1%(n=11) respectively.The  prevalence  of  both  
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endoscopic  and  histopathological  reflux  is  higher  in  patients  with  
nocturnal  symptoms.But  these  values  are  higher  compared  to  study  by  
Tug et al.   
Similarly Kiljander et al conducted a study about the prevalence of 
GERD in adult asthmatics in which they used 24 hour pH metry as the 
standard. The prevalence of reflux oesophagitis in their study was 36%.74
 Reflux oesophagitis is the sequelac and indicator of long standing and 
moderate to severe gasto-oestophageal reflux. It is more severe at the squamo-
columnar junction. It can extend upwards to many centimeters, but visible 
changes are usually confined to the distal 5 cm. Grading the extent of the 
macroscopic reflux oesophagitis is of great importance as it is the best 
measure of severity and the best predictor of outcome with treatment. In our 
study we did not try to establish the cause effective mechanisms of reflux and 
asthma.We screened the patients with intractable asthma for the presence of 
reflux oesophagitis ,thus it would be beneficial to the patients to start anti – 
reflux treatment in them.Many published reports favour the point that 
effective anti – reflux medical and surgical management will reduce the 
severity of asthma and reflux associated bronchospasm . 
 There is significant difference present in the prevalence of reflux 
esophagitis between males and females.Out of the 15 males 7 had reflux 
oesophagitis (46.67%) whereas in females 5 out of 15 had reflux 
oesophagitis(33.33%). 
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 The prevalence of reflux oesophagitis is higher in long standing and 
severe asthmatics.In this study reflux oesophagitis was present in 23.33% of 
patients with less than 5 years of disease and 33.3% of patients with 5 years or 
more of disease duration.Similarly out of the 21 patients with mild and 
moderate persistent asthma 33.33% (n=7) had reflux oesophagitis whereas out 
of the 9 patients with severe persistent asthma 55.55% (n =5) had reflux 
oesophagitis. 
 Thus this study clearly indicates that reflux oesophagitis is a common 
association in bronchial asthma patients with long standing and / or severe 
degree of disease.  
 In our study the prevalence of NERD (Negative Endoscopic Reflux 
Disease) is 44.44%. which is statistically significant. 
 
OTHER LESIONS: 
 Hiatus hernia as described by authors .ie, presence of > 2cm of gastric 
mucosa appearing above the diaphgram during endoscopy was present in only 
2 patients (6.67%) in this study.Out of these , one patient had reflux 
oesophagitis.But the western literature quotes the presence of hiatus hernia to 
the tune of upto 45% in various series. 
 Oesophageal candidiasis was present in only one patient which was 
stastically insignificant . After ruling out other possibilities, the only trigger 
which could be blamed was the oral steroid intake. 
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5 of the 30 patients had Antral gastritis (Male 3 : Female 2) had antral 
erosions and gastritis and two male patients had gastric ulcer 
(6.67%).Duodenitis was present in 3 cases ( 2females and one male).These 
disorders could be explained by the hyperacidity by the stress due to the 
disease or steroid intake. 
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CONCLUSIONS 
 
Following  are  the  conclusions  drawn in  the  study  of  30  cases  of  
bronchial  asthma  for  upper  gastrointestinal  endoscopic  changes. 
 
( Out of the 30 patients ,15 were males and 15 were females 
( Out of the 30 patients ,17 had abnormal endoscopy findings (56.67%) 
( Out of the 15 males studied ,10 had abnormal findings (66.67%) 
( Out of the 15 females studied , 7 had abnormal findings (46.67%) 
( There is a slightly higher prevalence of abnormal endoscopy findings 
in males with a ratio of 1.43:1 
( Abnormal endoscopy findings were not well correlated with the age 
group of the patients.But it has correlation with the duration of the 
illness 
( Out of the 13 patients with disease duration less than 5 years ,5 had 
abnormal findings (38.46%), where as out of the 17 patients with 
disease duration more than 5 years , 12 had abnormal findings (70.5%) 
( Among abnormal findings ,reflux oesophagitis stands first with 
prevalence of 40% (n = 12) among which Grade I oesophagitis is 
36.67% (n=11) and Grade II is 3.3% (n=1) 
( Reflux oesophagitis was slightly more prevalent in males than in 
females with a ratio of 1. 4:1 
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( Out of the 15 males ,7 had reflux oesophagitis (46.67%) & out of the 
15 females 5 had reflux oesophagitis (33-33%) 
( Pulled up gastro oesophageal junction consistent with hiatus hernia 
was found in 2 patients (6.67%).Out of this one had reflux 
oesophagitis. 
( Prevalence of reflux oesophagitis was slightly higher in longstanding 
asthmatics.Out of the 13 patients with disease duration less than 5 
years 4 had reflux oesophagitis (30.8%).Out of the 17 patients with 
disease duration more than 5 years, 8 had reflux oesophagitis (41.!8%) 
( Reflux oesophagitis was slightly more prevalent in diseases of severe 
degree.Out of the 21 patients with mild and moderate persistent 
asthma, 7 had reflux oesophagitis (33.33%);where as out of the 9 
patients with severe persistent asthma , 5 had reflux oesophagitis 
(55.55%) 
( Histopathological findings consistent with GERD were present in all 
the patients with reflux oesophagitis. 
( Out of the 18 patients who do not had reflux oesophagitis(NERD),8 
patients had histopathological findings consistent with GERD 
(44.44%) (NERD – higher percentage  in  this  study). 
( In  patients  with  mild  and  moderate  persistent  asthma, the  
prevalence  of  endoscopic  esophagitis  is  33.3%(n=7) and  
histopathologic  oesophagitis  is  61.9%(n=13). 
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( In  patients  with  severe  persistent  asthma, the  prevalence  of  
endoscopic  oesophagitis  is  55.5% (n=5)  and  histopathologic  
oesophagitis  is  77.7%(n=7) 
( In  patients  with  nocturnal  attacks,the  prevalence  of  endoscopic  
oesophagitis  is  58.3%( n=7)  and  histopathological  oesophagitis  is  
75%(n=9). 
( In  patients  without  nocturnal  attacks,the  prevalence  is  27.7%(n=5)  
and  61.1%  (n=11)  respectively. 
( Total prevalence of reflux oesophagitis (Endoscopy And Histology 
wise) is 66.67% (n=20) 
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SUMMARY 
 
The finding that prevalence of Reflux oesophagitis is more common in 
asthmatics reconfirmed in this study. 
Reflux oesophagitis is present in significant proportion of bronchial 
asthma patients of long standing illness and more severe disease pattern. 
Since presence of reflux oesophagitis worsens the disease pattern and hinders 
with effective control , these patients do not have satisfactory control of their 
asthma symptoms. 
This study established the Importance of histology in negative 
endoscopic reflux. Significant number of patients with negative endoscopy 
had histopathological evidence of oesophagitis, thereby proving the role of 
biopsy in GERD. 
  Antireflux therapy with proton pump inhibitors and prokinetics may 
provide symptomatic improvement in these patients which is beyond the 
scope of this study. 
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STUDY  ON  UPPER  GI  ENDOSCOPY 
FINDINGS  IN PATIENTS WITH BRONCHIAL ASTHMA 
     
PROFORMA 
 
 
NAME  :                                                 AGE  :                              SEX :                     IP/OP  NO : 
 
 
OCCUPATION  :                                  DURATION OF  ILLNESS:   
 
 
TREATMENT  :     REGULAR / IRREGULAR 
 
 
HT  :                 WT :                 BMI : 
 
 
 
SYMPTOMS :                                                                  GI  SYMPTOMS 
 
BREATHLESSNESS                                                 HEART BURNS 
 
WHEEZE                                                                    BELCHING 
 
COUGH                                                                       NAUSEA / VOMITING 
 
SPUTUM                                                                     POST CIBAL BLOATING 
 
NOCTURNAL EXACERBATION                            STICKINESS  IN THROAT  
 
SYMPTOM FREE  INTERVAL                                WATER INTAKE FOR EASY SWALLOWING                                
 
 
SIGNS  
 
DYSPHAGIA 
 
COMFORTABLE / DYSPNOEIC                                       VOICE   CHANGES 
 
CYANOSIS                                                                          SUPINE  POSTURE DIFFICULTIES 
 
ASTERIXIS 
 
CVS     : 
 
RS         :  
 
ABDOMEN   : 
 
CNS      : 
 
TRIGGERS  :                                                               OTHER  HISTORY 
 
 
UPPER  RESPIRATORY  INFECTION                                      HYPERTENSION 
 
EXERCISE                                                                                    PULMONARY  TB 
 
COLD AIR                                                                                     CAHD 
 
SMOKING                                                                                     H/O  ATOPY & ALLERGY 
 
POLLENS/DUST                                                                           FAMILY  H/O  ASTHMA 
 
DRUGS                                                                                           FAMILY   H/O  ALLERGY  
 
EMOTIONAL UPSET                                                                   SMOKING 
 
OTHERS                                                                                         ALCOHOLISM 
 
                                                                                                         OTHERS                                                                           
   
 
 
 
DRUGS                                                                                       INVESTIGATIONS                                        
 
STEROIDS  :  ORAL /INHALER /IV                                        Hb :                TC :             DC:    
 
XANTHINES                                                                              RBC  :                                                             
 
BETA – 2 AGONISTS                                                                URINE  COMPLETE  : 
 
OTHERS                                                                                      ECG    : 
   
                                                                                                     CHEST  X-RAY                                                                   
 
          USG  ABDOMEN  
                                   
 
 
 
                                     PULMONARY  FUNCTION TESTS: 
 
                                          
 
STUDY  ON  UPPER  GI  ENDOSCOPY 
FINDINGS  IN PATIENTS WITH BRONCHIAL ASTHMA 
PROFORMA 
 
NAME 
 
AGE 
 
SEX 
 
DURATION  OF  BRONCHIAL ASTHMA 
 
OG JUNCTION LENGTH 
 
GERD  :  +  / - 
 
LAX  OGD  :  YES/NO 
 
ESOPHAGITIS  :  YES/NO                                                                                    
                 
                    STAGE I/A       :                                                                                             
                                                                                                                  
                                STAGE 11/B     :                                                                            
 
                                STAGE 111/C   :                                                                                                                                      
 
                                STAGE 1V/D    : 
                                 
  
 STOMACH 
 
               FUNDUS 
 
              BODY 
 
              ANTRUM 
 
DUODENUM 
 
             FIRST  PART 
 
             SECOND  PART 
 
NERD          :  
   
 
BIOPSY   :  YES /NO   
 
 
SITE  OF  BIOPSY  : 
 
 
BRONCHIAL ASTHMA 
 
ESOPHAGITIS : Yes / No 
If Yes, Grade : 
 
BIOPSY : Yes / No 
If Yes, Findings: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MECHANISM OF EXTRA OESOPHAGEAL GERD 
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1 47 M 6 2/Wk 1/Wk Gr.I RE, antral gastritis 2 2 2 2 0 0
2 21 M 4 2-3/Wk Nil Hiatus hernia
3 31 M 5 1-2/Wk Nil 1 1 2 2 0 0
4 45 F 7 1-2/Wk Nil Gr.I RE 2 2 2 2 0 0
5 16 M 3 2-3/Wk Nil
6 48 F 7 Daily 3-4/Wk
7 55 M 8 Daily 3-4/Wk Gr.I RE 2 2 2 2 0 0
8 52 M 6 2-3/Wk Nil 1 1 2 2 0 0
9 34 M 6 1/Wk 2-3/Wk Gr.I RE, antral gastritis 2 2 2 2 0 0
10 27 F 3 1-2/Wk Nil Gr.I RE, antral gastritis 2 2 2 2 0 0
MASTER CHART
S
l
.
 
N
o
.
A
g
e
 
(
y
r
s
.
)
S
e
x
HISTOPATHOLOGICAL FINDINGS
D
u
r
a
t
i
o
n
 
o
f
 
A
s
t
h
m
a
 
(
Y
r
s
.
)
S
y
m
p
t
o
m
 
F
r
e
q
u
e
n
c
y
N
o
c
t
u
r
n
a
l
 
S
y
m
p
t
o
m
s
U
p
p
e
r
 
G
I
 
E
n
d
o
s
c
o
p
y
 
f
i
n
d
i
n
g
s
BC
T
L
e
n
g
t
h
 
o
f
 
P
a
p
i
l
l
a
e
E
o
s
i
n
o
p
h
i
l
 
i
n
u
a
s
i
o
n
N
e
u
t
r
o
p
h
i
l
 
i
n
u
a
s
i
o
n
N
e
c
r
o
s
i
s
/
E
r
o
s
i
n
D
I
S
S
l
.
 
N
o
.
A
g
e
 
(
y
r
s
.
)
S
e
x
HISTOPATHOLOGICAL FINDINGS
D
u
r
a
t
i
o
n
 
o
f
 
A
s
t
h
m
a
 
(
Y
r
s
.
)
S
y
m
p
t
o
m
 
F
r
e
q
u
e
n
c
y
N
o
c
t
u
r
n
a
l
 
S
y
m
p
t
o
m
s
U
p
p
e
r
 
G
I
 
E
n
d
o
s
c
o
p
y
 
f
i
n
d
i
n
g
s
11 60 F 7 Daily 2-3/Wk Gr.I RE 2 2 2 2 0 0
12 65 F 8 Daily 3-4/Wk Gr.I RE 2 2 2 2 0 0
13 38 F 6 2/Wk Nil Gr.I RE 2 2 2 2
14 53 F 6 2/Wk Nil 1 1 2 2
15 49 F 7 1/Wk Nil
16 32 F 4 1-2/Wk Nil
17 40 M 9 Daily 3-4/Wk Gr.II RE, Candidiasis 2 2 2 2 0 0
18 40 F 10 Daily 3-4/Wk 1 1 2 2
19 35 M 2 2-3/Wk Nil Duodenitis, Gr.I RE 2 2 2 2 0 0
20 20 F 2 1-2/Wk Nil Duodenitis
21 38 F 4 1-2/Wk Nil Antral gastritis
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22 41 M 8 Daily 3-4/Wk Gr.I RE, antral gastritis 2 2 2 2 0 0
23 13 M 2 2/Wk 2/Wk
24 40 F 7 Daily 2-3/Wk 1 1 2 2
25 14 F 3 1-2/Wk Nil
26 16 M 3 2-3/Wk Nil Hiatus hernia
27 29 M 6 2-3/Wk Nil Gr.I RE 2 2 2 2 0 0
28 29 M 6 2-3/Wk Nil 1 0 2 2
29 35 F 3 Daily 2-3/Wk 1 1 2 2 0 0
30 25 M 2 1-2/Wk Nil 0 0 2 2
